| Financial Year |
March 31 2023 |
| Monetary Funds |
310,822,326.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,765,579.63 |
| Accounts Receivable |
310,800,221.57 |
| Advances to Suppliers |
5,133,572.57 |
| Other Receivables |
2,424,655.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
283,571,306.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,637,490.32 |
| Total Current Assets |
925,699,304.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,623,913.15 |
| Investment Properties |
37,363,571.72 |
| Fixed Assetes |
227,900,653.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,887,136.07 |
| R&D expenses |
-- |
| Goodwill |
2,182,657.85 |
| Long-Term Deferred and Prepaid Expenses |
2,129,972.08 |
| Deferred Income Tax Assets |
26,000,295.22 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
322,268,199.40 |
| Total Assets |
1,247,967,504.09 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
124,987,521.30 |
| Accounts Payable |
188,463,851.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,898,588.94 |
| Taxes Payable |
3,053,218.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,804,171.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
7,943,275.65 |
| Sub-Total of Current Liabilities |
466,783,906.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,301,470.97 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,508,975.78 |
| Total Liabilities |
485,292,882.67 |
| Paid-In Capital(Or Share Stock) |
242,625,800.00 |
| Capital Surplus |
40,580,763.13 |
| Surplus Reserve |
75,672,983.06 |
| LESS:Treasury Stock |
28,098,181.80 |
| Undistributed Profits |
419,650,735.24 |
| Minority Stockholder's Interest |
12,101,231.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
750,573,389.66 |
| Owner's Equity（Stockholder's Equity） |
762,674,621.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,247,967,504.09 |
